Continuing Education Activity

Pudendal nerve entrapment syndrome is a chronic neuropathic pain disorder caused by compression or irritation of the pudendal nerve, often between the sacrospinous and sacrotuberous ligaments or within the Alcock canal. Etiologies include prolonged sitting, cycling, pelvic trauma, childbirth, and iatrogenic injury. Compression and ischemia impair neural conduction to the perineum, external genitalia, and anorectal region, producing burning or aching perineal pain worsened by sitting, along with sensory disturbances, sexual dysfunction, and lower urinary or bowel symptoms. Quality of life is often significantly impaired. Diagnosis relies on characteristic symptoms, exclusion of other causes, application of the Nantes criteria, and confirmation with pudendal nerve blocks. Management is stepwise, beginning with activity modification, pelvic floor physical therapy, and neuropathic pharmacotherapy, with image-guided nerve blocks, radiofrequency ablation, or surgical decompression reserved for refractory cases.

This activity enhances clinician competence in evaluating and managing pudendal nerve entrapment syndrome. Participants review evidence-based diagnostic and therapeutic strategies, including clinical assessment, procedural confirmation, multimodal pain management, and interventional or surgical options. Collaboration among interprofessional teams—including pain specialists, physical therapists, radiologists, urologists, gynecologists, and colorectal specialists—supports timely diagnosis, optimal treatment selection, and improved functional outcomes, reducing chronic disability and enhancing patient-centered care.

Objectives:

• Identify the clinical and diagnostic findings suggestive of pudendal nerve entrapment syndrome.
• Apply best practices for managing pudendal nerve entrapment syndrome and mitigating its potential complications.
• Improve patient awareness of pudendal nerve entrapment syndrome, including symptoms, risk factors, treatment options, and strategies to optimize quality of life and functional outcomes.
• Collaborate with the interprofessional team to educate, treat, and monitor patients experiencing pudendal nerve entrapment syndrome to improve functional and overall health outcomes.

Introduction

Pudendal neuralgia caused by pudendal nerve entrapment is a chronic and often severely disabling neuropathic pain syndrome.[1] The condition manifests within the sensory distribution of the pudendal nerve and affects both male and female patients. The most characteristic symptom, reported in over 50% of cases, is perineal pain exacerbated by sitting and relieved by standing or lying.[2] The syndrome is frequently misdiagnosed or underdiagnosed and often inappropriately treated, resulting in delayed initiation of appropriate management and substantial negative impact on quality of life. Chronic pain associated with pudendal nerve entrapment imposes significant mental and economic burdens. These factors warrant careful consideration during clinical assessment and therapeutic planning.

Anatomy of the Pudendal Nerve

The pudendal nerve arises from the ventral rami of the S2, S3, and S4 roots of the sacral plexus. This nerve carries sensory, motor, and autonomic fibers. Injury to the pudendal nerve primarily produces sensory deficits.[3] The nerve initially courses between the piriformis and coccygeus muscles, exiting the pelvic cavity through the greater sciatic foramen, ventral to the sacrotuberous ligament. This neural structure then passes medial to and beneath the sacrospinous ligament at the level of the ischial spine before reentering the pelvic cavity through the greater sciatic foramen.

The pudendal nerve continues within the pudendal canal, also termed the "Alcock canal." The terminal branches— the inferior rectal and perineal branches and the dorsal sensory nerve of the penis or clitoris—terminate in the ischioanal fossa.[4] Case reports have documented anatomical variability of the pudendal nerve.[5][6] For detailed anatomical information, refer to the companion StatPearls reference "Anatomy, Abdomen and Pelvis, Pudendal Nerve."

Types of Pudendal Nerve Compression Based on Anatomy

Pudendal nerve entrapment syndromes are classified into 4 types according to the anatomical site of nerve compression (see Image. Key Landmarks for Pudendal Nerve Entrapment). Type I involves entrapment of the pudendal nerve beneath the piriformis muscle as it exits the greater sciatic notch and is frequently associated with piriformis muscle spasm. Type II, the most common form, occurs at the level of the ischial spine and the entrance of the lesser sciatic notch, where the nerve passes between the sacrospinous and sacrotuberous ligaments. Type III is characterized by entrapment at the entrance of the Alcock canal, often in association with obturator internus muscle spasm. Type IV represents distal entrapment of the pudendal nerve’s terminal divisions.[7]

Etiology

Pudendal neuralgia can result from mechanical or nonmechanical injuries. Mechanical injury occurs through compression, traction, or stretching. Among mechanical causes, compression due to pudendal nerve entrapment is the most frequent etiology. Nonmechanical causes include viral infections, such as herpes zoster and HIV, multiple sclerosis, radiation therapy, and diabetes mellitus.[8] The first reported case of pudendal neuralgia was attributed to cycling, which was thought to result from continuous pressure on the Alcock canal.[9]

Pelvic surgery constitutes a common cause of pudendal neuralgia. Procedures for repair of pelvic organ prolapse are most frequently implicated, with incidence increasing when a mesh is used. Chronic persistent pain may necessitate mesh removal in some cases.[10][11] Additional surgical causes include midurethral sling procedures, hysterectomy, and anterior colporrhaphy. Direct trauma to the buttocks or back may also induce pudendal neuralgia.[12] Vaginal delivery causes substantial stretching of pelvic floor muscles by the fetal head, occasionally resulting in pudendal nerve injury.[13][14] Chronic constipation, excessive cycling, and prolonged sitting are additional contributing factors. Chronic perineal microtrauma from cycling can lead to fibrosis within the pudendal canal and the sacrospinous and sacrotuberous ligaments.

Epidemiology

Pudendal nerve entrapment is an uncommon syndrome, and its true prevalence is unknown. The International Pudendal Neuropathy Foundation estimates an incidence of 1 per 100,000, although the actual prevalence is believed to be substantially higher than reported.[15] Pudendal nerve entrapment syndrome may affect approximately 1% of the general population and represents nearly 4% of all patient consultations for pain management, with female patients affected more than twice as frequently as male patients.[16][17]

Pathophysiology

Direct compression of the pudendal nerve is frequently observable during decompressive surgery. Repetitive activities, including prolonged sitting and cycling, are the primary contributors. However, compression may also arise congenitally or develop from scarring following pelvic surgical procedures. Athletes who experience repeated falls, such as skiers and snowboarders, may develop pelvic scarring secondary to recurrent bruising and hematoma formation.

History and Physical

History

The classic symptom of pudendal nerve entrapment is perineal pain, exacerbated by sitting and relieved by standing or sitting on a toilet. The condition produces pain, numbness, and dysfunction within the distribution of the pudendal nerve, including the genitalia, perineum, rectum, and lower urinary tract. Urinary manifestations include urgency and frequency in both sexes, with painful ejaculation occurring in men. Sexual dysfunction may present as persistent arousal dysfunction, dyspareunia, vulvodynia, or male erectile disorders.[18] Sphincteric dysfunction can manifest as constipation, dysuria, fecal incontinence, and urinary hesitancy.[19] Patients may report a foreign body sensation within the anus, rectum, urethra, or vagina.

Physical Examination

Physical examination is generally unremarkable aside from the reproduction of pain.[20] Symptom localization depends on the site and severity of nerve entrapment. Compression at the piriformis produces spasms and tenderness of the piriformis muscle. Entrapment within the Alcock canal results in tenderness and spasms of the obturator internus muscle. Compromise at the ischial spine or sacrospinous ligament causes pain medial to the ischium.

Tenderness over the greater sciatic notch indicates nerve entrapment at that site. Rectal and vaginal examinations are recommended to exclude alternative diagnoses, such as prostatitis, and identify intrapelvic entrapment. Specific testing for pelvic nerve entrapments differentiates among potential sites of compression and provides objective information to guide clinical decision-making. Individual maneuvers are explained below.

Strength and resistance testing while sitting

With the patient sitting, thigh elevation, abduction, and adduction are assessed against resistance. Significant proximal leg weakness indicates involvement of the high lumbar roots or spinal nerves.[21] Pain or weakness on adduction suggests obturator nerve dysfunction, which may be due to impingement at the obturator foramen or adjacent to the obturator internus muscle.

Strength and resistance testing when supine

Each extended leg is raised against resistance applied by a hand at the knee while the patient is supine.[22][23] Passive rotation of the leg should then be performed with the hip and knee flexed (internal and external rotation), followed by assessment of resistance to abduction and adduction when the flexed thigh is internally rotated.[24] Symptoms produced by resisted abduction or adduction suggest involvement of the obturator internus or piriformis muscles. Aggravation of symptoms on elevation of the extended leg, but not with the leg flexed, indicates possible psoas muscle involvement. The presence of symptom aggravation with elevation of the extended leg, but not with elevation of the flexed leg (supine versus sitting), is indicative of potential pathology involving the psoas muscle.

Crossed leg traction test

Crossed-leg traction assesses symptom exacerbation or relief by pulling each leg upward and toward the contralateral side by approximately 10° while applying traction at the ankle. Relief of symptoms suggests involvement of the obturator internus or piriformis muscles.

Passive hip rotation test

Increased hip or groin pain with passive hip rotation suggests possible hip joint pathology.[25][26][27] This finding warrants correlation with the patient's history, functional assessment, and diagnostic studies to determine the underlying structural abnormalities.

Palpation of pelvic and perineal structures

With the patient standing, the sciatic notch is palpated for tenderness, which indicates piriformis sensitivity.[28] The sacroiliac ligament (superomedially) and sacrotuberous ligament (inferomedially) should also be assessed for tenderness or provocation of pudendal neuralgia. Tenderness of the retrosciatic area, located slightly inferior and medial to the greater sciatic notch, suggests pudendal nerve entrapment, including involvement of the sacrospinous ligaments.

Ischial tunnel syndrome, which may involve adhesions, scarring of the sciatic or posterior femoral cutaneous nerve at the hamstring origin, or inflammation from the obturator internus tendon under tension, may be detected by palpation of the lateral ischial tuberosity. Bursitis and inferior cluneal nerve involvement are identified by direct palpation of the ischial tuberosity. Obturator internus muscle tenderness is assessed by pressing the medial aspect of the ischial tuberosity.

Lumbar and spinal screening

Forward bending is used to screen for lumbar disk disease. Back extension detects facet syndrome. Twisting the spine to either side identifies lumbar annular tears. Lateral bending aggravates symptoms arising from ipsilateral gluteal or piriformis pathology.

Balance and hip stability

The Romberg test requires the patient to walk heel-to-toe along a straight line. This maneuver assesses hip-joint instability, sometimes observed in patients with poor balance.[29]

Evaluation

Pudendal nerve entrapment is a challenging condition to diagnose due to the absence of specific diagnostic tests. A thorough patient history and detailed physical examination are essential for accurate diagnosis.

The Nantes Criteria

Dr Roger Robert established the Nantes criteria for diagnosing pudendal nerve entrapment. The essential inclusion criteria are as follows:

• Pain corresponds to the anatomical distribution of the pudendal nerve. The pudendal nerve supplies the external genitalia and perineum. Pain may be superficial or deep, affecting the vulvovaginal and anorectal regions, as well as the distal urethra.
• Pain predominates in the sitting position. This pattern predisposes to nerve compression, as reduced nerve mobility increases vulnerability to compressive trauma from rigid ligamentous structures. The symptom reflects dynamic compression rather than the sitting position alone.
• Patients typically do not awaken at night due to pain, although difficulty falling asleep is common.
• No identifiable sensory loss is present. Superficial perineal sensory impairment indicates a sacral root lesion rather than pudendal nerve entrapment.
• Pain relief with a pudendal nerve block supports the diagnosis. This criterion is nonspecific, as other perineal conditions can cause pain within the distribution of the pudendal nerve. A negative block does not necessarily exclude pudendal nerve entrapment if the block is incorrectly placed or performed too distally.[30]

Complementary diagnostic criteria include the following:

• Allodynia or hyperpathia
• Foreign body sensation or heaviness in the rectum or vagina
• Progressive pain that peaks in the evening and resolves when the patient lies down and sleeps
• Predominantly unilateral pain
• Pain described as burning, shooting, or stabbing and associated with numbness
• Posteriorly prominent pain triggered minutes or hours after defecation
• Tenderness elicited around the ischial spine during a digital vaginal or rectal examination
• Abnormal findings on neurophysiological testing

Exclusion criteria include the following:

• Pain located exclusively outside the pudendal nerve territory, such as the hypogastrium, coccyx, pubis, or gluteal region
• Pain associated with pruritus, suggestive of a skin lesion
• Pain that is entirely paroxysmal
• Imaging evidence identifying the cause of pain 

The Nantes criteria have been validated by numerous European clinicians with extensive experience in managing similar conditions. Fulfillment of all Nantes criteria generally obviates the need for further investigation. Additional evaluation is recommended if the patient does not meet the criteria.

Associated signs of pudendal nerve entrapment include erectile dysfunction, urinary frequency or pain with bladder fullness, and postejaculatory pain. Patients may experience pain localized to the buttocks, medial thigh—indicating possible obturator nerve involvement—and the suprapubic region. Pain often worsens hours after sexual intercourse and may be referred along the sciatic nerve distribution. Notably, electrophysiological tests may show normal results despite these symptoms.

Diagnostic Tests

Quantitative warm-sensory threshold testing assesses the ability of nerves to detect graded changes in temperature and vibration. Compressed nerves demonstrate reduced efficiency in transmitting these sensory signals. Patients with nerve injuries often cannot perceive gradual temperature changes until the probe reaches a level that produces painful burning.[31][32] The warm sensory threshold detection test is the most commonly employed method and can be performed easily in a clinician's office or clinic. Biothesiometry, which assesses vibratory sensation, may be used similarly to identify loss of vibrational sensitivity.

Pudendal nerve terminal motor latency testing is a neurophysiological examination that measures the time required for a nerve signal to travel from the ischial spine to the anal sphincter. This test is more invasive, technically challenging, and more uncomfortable for the patient than warm sensory threshold testing.[33] High-frequency ultrasonography aids in detecting the site of nerve compression. Compressed nerves and associated veins appear flattened, whereas inflamed nerves appear edematous.

Doppler ultrasound assists in the diagnosis of pudendal nerve entrapment. Because the pudendal nerve and vessels travel together in a neurovascular bundle, nerve compression is often accompanied by venous compression, which can be detected by Doppler ultrasound.[34] Magnetic resonance imaging (MRI) of the pelvis is recommended to rule out alternative causes of chronic pain. Advances in MRI techniques for evaluating peripheral nerves provide detailed visualization of anatomy, fascicular architecture, nerve blood supply, and 3-dimensional structure.[35] MRI also aids in localizing the exact site of entrapment. Imaging is strongly recommended prior to any surgery for pudendal nerve entrapment.[36]

Functional MRI evaluates nerve integrity based on biological properties. This technique is currently considered experimental and not definitive. No specific or consistent radiological findings have been established for pudendal nerve entrapment, and further research is required.

Diagnostic nerve blocks without guidance may be performed vaginally in women and transperineally in men. Immediate pain relief following the block indicates pudendal nerve pathology as the likely cause. Absence of relief does not exclude entrapment, as technical or procedural errors may occur. Image guidance using fluoroscopy, ultrasound, or computed tomography significantly increases the reliability of pudendal nerve blocks.[37] Pudendal nerve block injections with local anesthetic, particularly when administered directly into the Alcock canal under image guidance, are recommended to confirm the diagnosis and identify patients most likely to benefit from decompressive surgery.[38] Approximately 20% of blocks fail due to physician error, inexperience, or inadequate training.[39][40]

Treatment / Management

Conservative Treatments 

Avoidance of painful stimuli is a primary component of treatment. For example, cycling-related pain warrants recommending appropriate padding or cessation of the sport. Other activities to avoid may include hip flexion exercises, jogging, rowing, gymnastics, skiing, and snowboarding. Patients experiencing pain during prolonged sitting should implement lifestyle modifications to minimize that activity, such as using a standing workstation. Approximately 20% to 30% of patients achieve relief with conservative measures alone.

Physical therapy

Pelvic floor physical therapy is most effective for patients whose pain arises from muscle spasms, including levator ani syndrome and similar myofascial disorders. Therapy facilitates relaxation of the pelvic floor muscles by releasing spasms and lengthening muscle fibers. A treatment course of 6 to 12 weeks is commonly recommended. Transcutaneous electrical nerve stimulation (TENS) may be added to physical therapy and appears beneficial.[41][42][43] TENS is low risk, relatively inexpensive, widely available, and noninvasive.

Cognitive behavioral therapy

Behavioral therapy has demonstrated utility in various chronic pelvic pain syndromes, although it has not been specifically studied for pudendal nerve entrapment.[44][45] This therapy is generally recommended as an adjunctive treatment when psychological issues are present, including anxiety, depression, hopelessness, or emotional instability.[46] Frustration and depression are especially prevalent in patients with chronic neuropathic pain who have experienced little or no relief from previous treatments.

Pharmacologic therapy

Drugs that may be used include analgesics, muscle relaxants, and anticonvulsants. No randomized trials have evaluated the relative efficacy of these medications or determined which combinations are most effective. Multiple medications from different drug classes are often employed. A typical regimen may consist of a tricyclic antidepressant, such as amitriptyline; a serotonin-norepinephrine reuptake inhibitor, such as duloxetine; and a neurotransmitter analog, such as gabapentin or pregabalin. Opioids are avoided whenever possible. Commonly used medications include the following:

• Amitriptyline, starting at 10 mg at bedtime and gradually increasing to 50 mg
• Clonidine, 0.1 mg at bedtime, which helps with pain and also serves as a sleep aid
• Duloxetine, a selective serotonin-norepinephrine reuptake inhibitor, starting at 30 mg daily for 7 days, then increasing to 60 mg daily

  • No additional benefit is observed with further increases in dosage.
• Gabapentin, with or without pregabalin, starting at 300 mg 3 times daily and gradually increasing to a maximum of 900 mg 3 times daily
• Pregabalin, with or without gabapentin, starting at 75 mg twice daily and gradually increasing to 300 mg twice daily

Medication alone may be insufficient for complete symptom relief in many patients. Consequently, analgesics, muscle relaxants, and anticonvulsants are typically employed as part of a multimodal approach.

Pudendal nerve block

Infiltration with a local anesthetic or steroid around the pudendal nerve is a primary treatment for pudendal nerve pain. The block may be administered with or without guidance using ultrasonography, fluoroscopy, or CT, with CT being the most consistently reported technique.[47][48] Image guidance is recommended to achieve more accurate and reliable results.

No single medication or combination has been standardized. A commonly used mixture includes 1% lidocaine, 0.25% bupivacaine, and a corticosteroid such as triamcinolone. The short-acting anesthetic produces effects within 20 minutes; bupivacaine provides longer-lasting analgesia; and the corticosteroid effect begins approximately 3 to 5 days and can persist for about a month. A repeat injection may be administered if required.[49]

The average success rate of pudendal nerve blocks is approximately 80%, with 25% of patients reporting pain relief lasting longer than a month. Although effective, evidence indicates that repeated therapeutic blocks may lose efficacy after 2 years.[50] For patients receiving ongoing injections, ultrasonography is recommended to minimize costs and reduce cumulative exposure to ionizing radiation. Detailed procedural guidance is available in the companion StatPearls reference "Pudendal Nerve Block." A comprehensive description of all conservative therapies, medications, and procedural options for pudendal nerve entrapment is provided in the companion StatPearls reference "Pudendal Neuralgia."

Surgical Therapies

Surgery is indicated in cases of persistent pudendal nerve entrapment that do not respond to noninvasive or minimally invasive interventions. The different options are explained below.

Cryotherapy

Early reports of cryotherapy in small patient series demonstrate promising results, consistent with outcomes observed in other neuropathies.[51] However, evidence regarding efficacy and safety remains insufficient to support routine use outside of clinical trials.

Dorsal root ganglion stimulation

Dorsal root ganglion stimulation is an investigational technique and a potentially promising treatment for chronic pain associated with pudendal neuralgia.[52][53] The procedure involves surgically implanting a device that delivers electrical signals to the dorsal root ganglion in the spinal cord, thereby modulating pain signals from the pudendal nerve.[54][55] Case reports and small series have demonstrated successful pain relief in patients with refractory pudendal neuralgia, but additional research is required to evaluate safety, efficacy, and optimal patient selection.[56]

Complications include lead migration or fracture, treatment failure, and the need for surgical revision. Patients should be counseled on potential risks, including adverse outcomes. Further studies are necessary to determine which patients are most likely to benefit from this approach.[57][58]

Lipofilling

Lipofilling is a relatively new, experimental treatment for pudendal neuralgia. Venturi first described this technique in 15 female patients, involving autologous injection of adipose tissue with stem cells into the Alcock canal. Ten patients demonstrated significant pain reduction and improved quality of life at 6 months. Given the small sample size, single-study design, and absence of a control group, additional research is required before recommending this therapy outside a clinical trial.[59]

Pulsed radiofrequency ablation

Pulsed radiofrequency ablation is a novel method of pudendal neuromodulation. This procedure is considered safer than continuous radiofrequency treatment because it reduces the risk of heat-related complications. The technique employs pulsed electromagnetic radiation to induce neuromodulation and shows potential for treating chronic, refractory neuropathic pudendal neuralgia.[60]

Compared with pudendal nerve blocks, pulsed radiofrequency ablation provides equivalent pain relief with a substantially longer duration, lasting up to 3 months.[61] Several recent studies report persistent pain relief in 89% of 90 patients followed for 6 months after pulsed radiofrequency ablation therapy.[62][63] Despite these promising results, current evidence is insufficient to justify widespread clinical use.

Sacral neuromodulation

This minimally invasive treatment employs a peripheral nerve stimulator to modulate neural activity of the pudendal nerve in the ischioanal fossa. The first case report by Valovska described the successful management of a patient with pudendal neuralgia using minimally invasive transforaminal sacral neurostimulation.[64] Results from a prospective trial of 27 patients with refractory pudendal neuralgia demonstrated promising results with conus medullaris neuromodulation: 20 of 27 patients achieved a response, defined as at least a 5% reduction in pain, and all responders experienced long-term relief.[65]

A systematic review evaluating pudendal nerve stimulation in 35 patients across 3 studies with long-term follow-up identified several positive responders, although statistical significance was not assessed.[66] In a study by Vancaillie et al, results showed a reduction in Visual Analog Scale scores from 8.32 to 4.88 (P < 0.001), and 35 of 43 patients reported improved quality of life. Device explantation due to infection or hardware malfunction occurred in 10 of 43 patients.[67]

Sacral neuromodulation is frequently employed as a treatment of last resort for patients who have failed all other interventions, including surgical decompression. Approximately two-thirds of such patients respond favorably to neuromodulation.[68] Optimal stimulation parameters and standardized protocols have not been established. However, evidence suggests that higher frequencies exceeding 20 Hz may yield superior outcomes. Sacral neuromodulation is safe, effective, minimally invasive, and widely available, yet it remains generally underutilized for pudendal neuralgia. While surgical decompression is typically considered the preferred long-term curative therapy for most patients with pudendal nerve entrapment, sacral neuromodulation is appropriate for patients who are not surgical candidates or have failed decompressive procedures.

Surgical decompression

Direct surgical release of the pudendal nerve within the Alcock canal is considered the most effective long-term treatment and potential cure for pudendal nerve entrapment. Four approaches are described: transperineal, transgluteal, transischiorectal, and laparoscopic.[69] All techniques involve some destruction of nerve fibers but achieve equivalent benefit by removing the underlying cause of compressive neuropathy.[70] Overall success rates for surgical decompression range from 60% to 80%, with an average of approximately 70%.[71] The objective of decompressive surgery is to free the nerve from entrapment completely, restoring unrestricted mobility.

Laparoscopic transperitoneal release of the pudendal nerve and artery was evaluated in a retrospective series of 235 patients, demonstrating a significant reduction in perineodynia (P < 0.001) and improved pain at 3 months.[72] Perioperative complications occurred in 18.7% of patients, with hemorrhage from pudendal artery laceration being the most significant. The laparoscopic approach shows promise but requires further large-scale prospective studies to confirm safety and efficacy.

A modified laparoscopic procedure incorporating an omental flap, known as the Istanbul technique, has been described in 27 patients. Outcomes were assessed using pain scores and quality-of-life measures. Approximately 80% of patients reported greater than 80% pain reduction at 6 months, demonstrating substantial efficacy. Laparoscopy provides an enhanced surgical field with magnification, permits placement of a neuromodulation electrode as a backup, and allows subsequent removal if not required; however, it presents a steep learning curve.[73] Placement of a neuromodulation electrode during decompression appears reasonable in selected complex or severe cases. Laparoscopic pudendal nerve decompression with intraoperative neurophysiological monitoring has also been reported, showing significant pain relief and improved quality of life in preliminary studies involving a small cohort of carefully selected patients. Larger studies are necessary to validate these results and establish evidence-based criteria for patient selection.[74]

Differential Diagnosis

Pudendal neuralgia is primarily a diagnosis of exclusion since no confirmatory diagnostic test exists. Other conditions that should be considered prior to establishing this diagnosis include the following:

• Perineal stretching resulting from childbirth trauma
• Chronic pelvic pain syndrome
• Chronic prostatitis
• Coccygodynia
• Compression from external sources, including benign or malignant tumors and metastases
• Complex regional pain syndrome, a chronic pain condition typically affecting a limb following injury
• Interstitial cystitis
• Ischial bursitis
• Sacral neuropathy caused by injury to the sacral plexus
• Piriformis syndrome
• Prostatitis
• Prostatodynia
• Sacroiliac joint dysfunction
• Superficial dermatologic infections in areas innervated by the pudendal nerve
• Vulvar vestibulitis
• Vulvodynia [75]

Accurate identification of conditions mimicking pudendal neuralgia is essential to ensure targeted and effective treatment. A thorough clinical evaluation, supported by imaging and laboratory tests as indicated, helps exclude alternative diagnoses and prevents inappropriate interventions.

Prognosis

Pudendal neuralgia caused by pudendal nerve entrapment can profoundly impair quality of life, although life expectancy is not affected. The overall response to pudendal nerve blocks in appropriately selected patients is approximately 80%, but pain relief typically persists for only about 30 days. Repeat injections or alternative therapies are required when symptoms recur. The most durable long-term outcomes are achieved with decompressive surgery, which yields response rates of 60% to 80%. Patients who do not respond to decompressive surgery, potentially up to 80%, may still experience symptomatic relief from sacral neuromodulation.

Complications

Complications associated with pudendal nerve blocks are uncommon. Reported adverse events comprise the following:

• Abscess formation
• Accidental intravascular injection of a local anesthetic, leading to cardiovascular and central nervous system toxicity
• Hematoma from injury to the pudendal artery or surrounding vessels
• Infection or pain at the injection site
• Laceration of the vaginal mucosa

Manifestations of accidental intravascular injection of a local anesthetic may include palpitations, hypotension, bradycardia, dysarthria, tinnitus, drowsiness, confusion, loss of consciousness, or convulsions. Pudendal decompression surgery may also produce complications, though these conditions are rare. Potential surgical risks include damage to a small nerve branch, which may be repaired microsurgically if necessary, or injury or transection of the sacrotuberous ligament, which may cause pelvic instability. Employing a midline vertical incision helps avoid this complication. Postoperative pain relief is typically gradual, decreasing over months; this delayed improvement reflects the normal healing process rather than a surgical complication.

Deterrence and Patient Education

Patients should be instructed to avoid painful stimuli and actively engage in physiotherapy. Lifestyle modifications, including avoidance of aggravating activities and use of appropriate seating pads, are essential components of the overall treatment plan.

Pearls and Other Issues

Patients with chronic pelvic pain and confirmed pelvic pathology who fail to respond to standard therapy should be reevaluated for possible pudendal nerve entrapment. Minimally invasive therapies should be attempted first, including conservative measures with lifestyle modifications, physical therapy, TENS, and pudendal nerve blocks. Successful relief following a diagnostic pudendal nerve block in the Alcock canal strongly suggests pudendal nerve entrapment and indicates a reasonable expectation of benefit from decompressive surgery. Opioid medications should be avoided whenever possible to reduce the risk of dependency.

Image guidance is recommended to improve injection accuracy; ultrasound is preferred over ionizing radiation for repeated injections. Although no definitive analgesic, anesthetic, dosage, or mixture exists for pudendal nerve block injections, combining short- and long-acting local anesthetics with a corticosteroid is reasonable to achieve maximal relief. Clinicians should be aware that the efficacy of repeated pudendal nerve blocks may decline after 2 years.

Early involvement of psychology and pain management is critical in treatment planning for chronic pelvic pain. Patients should receive comprehensive information on diagnostic testing, available treatment options informed by local expertise and resources, and realistic expectations for outcomes. Not all pudendal neuralgias are caused by nerve entrapment, and the pudendal nerve may be compressed at various anatomical locations. Consequently, uniform therapy is not effective for all patients.

Chronic pain syndromes often lead to frustration and clinical depression, with suicide reported in some cases of pudendal neuralgia.[76] A study by Raynor et al involving 1024 patients assessed the prevalence of depression in chronic pain and its impact on health care costs. The study categorized 60.8% of patients as having probable depression and 33.8% as having severe depression based on questionnaire responses. Patients with depression also incurred higher healthcare costs (P = 0.001).[77] Similar findings were observed in the Medical Expenditure Panel Survey analysis of 26,671 patients from 2008 to 2011, which demonstrated that higher pain levels correlate with higher total healthcare expenditures.[78]

Enhancing Healthcare Team Outcomes

Pudendal neuralgia due to pudendal nerve entrapment is an uncommon neuropathic disorder that markedly reduces quality of life and can lead to significant disability. Misdiagnosis is frequent, and many patients undergo ineffective treatments for alternative suspected conditions before the correct diagnosis is established. The Nantes diagnostic criteria were developed and validated by an interprofessional team to facilitate earlier recognition and management of pudendal nerve entrapment. Additional investigation is generally unnecessary when all criteria are satisfied; however, further evaluation is warranted if any criterion is not met.

MRI is recommended to exclude alternative and potentially reversible causes of chronic pelvic pain. Management must be individualized and often requires durable lifestyle modifications and dedicated physical therapy. Core therapeutic strategies include conservative measures, physical therapy with or without TENS, pharmacologic treatment, ultrasound- or CT-guided nerve blocks, decompression surgery, and neuromodulation.

Pudendal nerve entrapment and neuropathy are relatively understudied disorders. Few high-quality prospective studies exist, and the literature lacks comparative trials with appropriate control groups, standardized inclusion criteria, consistent definitions of treatment success, and long-term outcome data. Thus, the information provided in this review is derived from the best available evidence and expert consensus. Robust prospective research is urgently needed to establish more effective and standardized treatment pathways. Optimal management requires a well-coordinated interprofessional team that may include pain specialists, surgeons, anesthesiologists, nurses, radiologists, psychologists, gynecologists, urologists, and physiotherapists. Collaboration across these disciplines is essential to improve patient outcomes and ensure comprehensive care for this complex neuropathic condition.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Ploteau S, Labat JJ, Riant T, Levesque A, Robert R, Nizard J. New concepts on functional chronic pelvic and perineal pain: pathophysiology and multidisciplinary management. Discov Med. 2015 Mar;19(104):185-92. [PubMed: 25828522]

2.

Robert R, Prat-Pradal D, Labat JJ, Bensignor M, Raoul S, Rebai R, Leborgne J. Anatomic basis of chronic perineal pain: role of the pudendal nerve. Surg Radiol Anat. 1998;20(2):93-8. [PubMed: 9658526]

3.

Leslie SW, Antolak S, Feloney MP, Soon-Sutton TL. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 12, 2024. Pudendal Neuralgia. [PubMed: 32965917]

4.

Kinter KJ, Newton BW. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 10, 2023. Anatomy, Abdomen and Pelvis, Pudendal Nerve. [PubMed: 32134612]

5.

Maldonado PA, Chin K, Garcia AA, Corton MM. Anatomic variations of pudendal nerve within pelvis and pudendal canal: clinical applications. Am J Obstet Gynecol. 2015 Nov;213(5):727.e1-6. [PubMed: 26070708]

6.

Montoya TI, Calver L, Carrick KS, Prats J, Corton MM. Anatomic relationships of the pudendal nerve branches. Am J Obstet Gynecol. 2011 Nov;205(5):504.e1-5. [PubMed: 21889763]

7.

Filler AG. Diagnosis and treatment of pudendal nerve entrapment syndrome subtypes: imaging, injections, and minimal access surgery. Neurosurg Focus. 2009 Feb;26(2):E9. [PubMed: 19323602]

8.

Ramsden CE, McDaniel MC, Harmon RL, Renney KM, Faure A. Pudendal nerve entrapment as source of intractable perineal pain. Am J Phys Med Rehabil. 2003 Jun;82(6):479-84. [PubMed: 12820792]

9.

Leibovitch I, Mor Y. The vicious cycling: bicycling related urogenital disorders. Eur Urol. 2005 Mar;47(3):277-86; discussion 286-7. [PubMed: 15716187]

10.

Marcus-Braun N, Bourret A, von Theobald P. Persistent pelvic pain following transvaginal mesh surgery: a cause for mesh removal. Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):224-8. [PubMed: 22464208]

11.

Sancak EB, Avci E, Erdogru T. Pudendal neuralgia after pelvic surgery using mesh: Case reports and laparoscopic pudendal nerve decompression. Int J Urol. 2016 Sep;23(9):797-800. [PubMed: 27250921]

12.

Heinze K, Nehiba M, van Ophoven A. [Neuralgia of the pudendal nerve following violent trauma: analgesia by pudendal neuromodulation]. Urologe A. 2012 Aug;51(8):1106-8. [PubMed: 22751935]

13.

Lien KC, Morgan DM, Delancey JO, Ashton-Miller JA. Pudendal nerve stretch during vaginal birth: a 3D computer simulation. Am J Obstet Gynecol. 2005 May;192(5):1669-76. [PubMed: 15902175]

14.

Sultan AH, Kamm MA, Hudson CN. Pudendal nerve damage during labour: prospective study before and after childbirth. Br J Obstet Gynaecol. 1994 Jan;101(1):22-8. [PubMed: 8297863]

15.

Hibner M, Desai N, Robertson LJ, Nour M. Pudendal neuralgia. J Minim Invasive Gynecol. 2010 Mar-Apr;17(2):148-53. [PubMed: 20071246]

16.

Guo KK, Wang L, Liu F, Niu JJ, Wang C, You SH, Feng ZG, Lu GJ. Sacral Nerve Stimulation in Patients With Refractory Pudendal Neuralgia. Pain Physician. 2022 Jul;25(4):E619-E627. [PubMed: 35793186]

17.

Spinosa JP, de Bisschop E, Laurençon J, Kuhn G, Dubuisson JB, Riederer BM. [Sacral staged reflexes to localize the pudendal compression: an anatomical validation of the concept]. Rev Med Suisse. 2006 Oct 25;2(84):2416-8, 2420-1. [PubMed: 17121249]

18.

Waldinger MD, Venema PL, van Gils AP, Schweitzer DH. New insights into restless genital syndrome: static mechanical hyperesthesia and neuropathy of the nervus dorsalis clitoridis. J Sex Med. 2009 Oct;6(10):2778-87. [PubMed: 19732313]

19.

Shafik A, El Sibai O, Shafik IA, Shafik AA. Role of sacral ligament clamp in the pudendal neuropathy (pudendal canal syndrome): results of clamp release. Int Surg. 2007 Jan-Feb;92(1):54-9. [PubMed: 17390916]

20.

Martin R, Martin HD, Kivlan BR. NERVE ENTRAPMENT IN THE HIP REGION: CURRENT CONCEPTS REVIEW. Int J Sports Phys Ther. 2017 Dec;12(7):1163-1173. [PMC free article: PMC5717491] [PubMed: 29234567]

21.

Alexander CE, Weisbrod LJ, Varacallo MA. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 27, 2024. Lumbosacral Radiculopathy. [PubMed: 28613587]

22.

Das JM, Dua A, Nadi M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Oct 6, 2024. Straight Leg Raise Test (Lasegue sign) [PubMed: 31424883]

23.

Camino Willhuber GO, Piuzzi NS. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 12, 2023. Straight Leg Raise Test. [PubMed: 30969539]

24.

Filler AG, Haynes J, Jordan SE, Prager J, Villablanca JP, Farahani K, McBride DQ, Tsuruda JS, Morisoli B, Batzdorf U, Johnson JP. Sciatica of nondisc origin and piriformis syndrome: diagnosis by magnetic resonance neurography and interventional magnetic resonance imaging with outcome study of resulting treatment. J Neurosurg Spine. 2005 Feb;2(2):99-115. [PubMed: 15739520]

25.

Frank RM, Slabaugh MA, Grumet RC, Virkus WW, Bush-Joseph CA, Nho SJ. Posterior hip pain in an athletic population: differential diagnosis and treatment options. Sports Health. 2010 May;2(3):237-46. [PMC free article: PMC3445101] [PubMed: 23015944]

26.

Kelly M, Secomb J. Associations Between Hip Pathology, Hip and Groin Pain, and Injuries in Hockey Athletes: A Clinical Commentary. Int J Sports Phys Ther. 2024;19(5):625-641. [PMC free article: PMC11065768] [PubMed: 38707850]

27.

Wong SE, Cogan CJ, Zhang AL. Physical Examination of the Hip: Assessment of Femoroacetabular Impingement, Labral Pathology, and Microinstability. Curr Rev Musculoskelet Med. 2022 Apr;15(2):38-52. [PMC free article: PMC9076795] [PubMed: 35171468]

28.

Hicks BL, Lam JC, Varacallo MA. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 4, 2023. Piriformis Syndrome. [PubMed: 28846222]

29.

Forbes J, Munakomi S, Cronovich HA. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 13, 2023. Romberg Test. [PubMed: 33085334]

30.

Labat JJ, Riant T, Robert R, Amarenco G, Lefaucheur JP, Rigaud J. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn. 2008;27(4):306-10. [PubMed: 17828787]

31.

Walk D, Sehgal N, Moeller-Bertram T, Edwards RR, Wasan A, Wallace M, Irving G, Argoff C, Backonja MM. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain. 2009 Sep;25(7):632-40. [PubMed: 19692806]

32.

Beco J, Seidel L, Albert A. Normative values of skin temperature and thermal sensory thresholds in the pudendal nerve territory. Neurourol Urodyn. 2015 Aug;34(6):571-7. [PubMed: 24782126]

33.

Tetzschner T, Sørensen M, Lose G, Christiansen J. Pudendal nerve function during pregnancy and after delivery. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(2):66-8. [PubMed: 9297593]

34.

Mollo M, Bautrant E, Rossi-Seignert AK, Collet S, Boyer R, Thiers-Bautrant D. Evaluation of diagnostic accuracy of Colour Duplex Scanning, compared to electroneuromyography, diagnostic score and surgical outcomes, in Pudendal Neuralgia by entrapment: a prospective study on 96 patients. Pain. 2009 Mar;142(1-2):159-63. [PubMed: 19195783]

35.

Wadhwa V, Hamid AS, Kumar Y, Scott KM, Chhabra A. Pudendal nerve and branch neuropathy: magnetic resonance neurography evaluation. Acta Radiol. 2017 Jun;58(6):726-733. [PubMed: 27664277]

36.

Levesque A, Bautrant E, Quistrebert V, Valancogne G, Riant T, Beer Gabel M, Leroi AM, Jottard K, Bruyninx L, Amarenco G, Quintas L, Picard P, Vancaillie T, Leveque C, Mohy F, Rioult B, Ploteau S, Labat JJ, Guinet-Lacoste A, Quinio B, Cosson M, Haddad R, Deffieux X, Perrouin-Verbe MA, Garreau C, Robert R. Recommendations on the management of pudendal nerve entrapment syndrome: A formalised expert consensus. Eur J Pain. 2022 Jan;26(1):7-17. [PubMed: 34643963]

37.

Choi SS, Lee PB, Kim YC, Kim HJ, Lee SC. C-arm-guided pudendal nerve block: a new technique. Int J Clin Pract. 2006 May;60(5):553-6. [PubMed: 16700853]

38.

Engeler DS, Baranowski AP, Dinis-Oliveira P, Elneil S, Hughes J, Messelink EJ, van Ophoven A, Williams AC., European Association of Urology. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013 Sep;64(3):431-9. [PubMed: 23684447]

39.

Ford JM, Owen DJ, Coughlin LB, Byrd LM. A critique of current practice of transvaginal pudendal nerve blocks: a prospective audit of understanding and clinical practice. J Obstet Gynaecol. 2013 Jul;33(5):463-5. [PubMed: 23815197]

40.

Antolak S, Antolak C, Lendway L. Measuring the Quality of Pudendal Nerve Perineural Injections. Pain Physician. 2016 May;19(4):299-306. [PubMed: 27228517]

41.

Eid MM, Rawash MF, Sharaf MA, Eladl HM. Effectiveness of transcutaneous electrical nerve stimulation as an adjunct to selected physical therapy exercise program on male patients with pudendal neuralgia: A randomized controlled trial. Clin Rehabil. 2021 Aug;35(8):1142-1150. [PubMed: 33611923]

42.

Vallinga MS, Spoelstra SK, Hemel IL, van de Wiel HB, Weijmar Schultz WC. Transcutaneous electrical nerve stimulation as an additional treatment for women suffering from therapy-resistant provoked vestibulodynia: a feasibility study. J Sex Med. 2015 Jan;12(1):228-37. [PubMed: 25388372]

43.

Sikiru L, Shmaila H, Muhammed SA. Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial. Int Braz J Urol. 2008 Nov-Dec;34(6):708-13; discussion 714. [PubMed: 19111075]

44.

Masheb RM, Kerns RD, Lozano C, Minkin MJ, Richman S. A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy. Pain. 2009 Jan;141(1-2):31-40. [PMC free article: PMC2728361] [PubMed: 19022580]

45.

Desrochers G, Bergeron S, Khalifé S, Dupuis MJ, Jodoin M. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther. 2010 Feb;48(2):106-15. [PubMed: 19879555]

46.

Beerten SG, Calabrò RS. Pudendal Neuralgia: The Need for a Holistic Approach-Lessons From a Case Report. Innov Clin Neurosci. 2021 Apr-Jun;18(4-6):8-10. [PMC free article: PMC8667704] [PubMed: 34980976]

47.

Fanucci E, Manenti G, Ursone A, Fusco N, Mylonakou I, D'Urso S, Simonetti G. Role of interventional radiology in pudendal neuralgia: a description of techniques and review of the literature. Radiol Med. 2009 Apr;114(3):425-36. [PubMed: 19277838]

48.

Mamlouk MD, vanSonnenberg E, Dehkharghani S. CT-guided nerve block for pudendal neuralgia: diagnostic and therapeutic implications. AJR Am J Roentgenol. 2014 Jul;203(1):196-200. [PubMed: 24951215]

49.

Ghanavatian S, Leslie SW, Derian A. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 2, 2024. Pudendal Nerve Block. [PubMed: 31855362]

50.

Basol G, Kale A, Gurbuz H, Gundogdu EC, Baydilli KN, Usta T. Transvaginal pudendal nerve blocks in patients with pudendal neuralgia: 2-year follow-up results. Arch Gynecol Obstet. 2022 Oct;306(4):1107-1116. [PubMed: 35633372]

51.

Prologo JD, Lin RC, Williams R, Corn D. Percutaneous CT-guided cryoablation for the treatment of refractory pudendal neuralgia. Skeletal Radiol. 2015 May;44(5):709-14. [PubMed: 25511935]

52.

Han A, Carayannopoulos AG. Spinal Cord Stimulation: The Use of Neuromodulation for Treatment of Chronic Pain. R I Med J (2013). 2020 May 01;103(4):23-26. [PubMed: 32357589]

53.

Esposito MF, Malayil R, Hanes M, Deer T. Unique Characteristics of the Dorsal Root Ganglion as a Target for Neuromodulation. Pain Med. 2019 Jun 01;20(Suppl 1):S23-S30. [PMC free article: PMC6544557] [PubMed: 31152179]

54.

Hunter CW, Yang A. Dorsal Root Ganglion Stimulation for Chronic Pelvic Pain: A Case Series and Technical Report on a Novel Lead Configuration. Neuromodulation. 2019 Jan;22(1):87-95. [PubMed: 30067887]

55.

Huygen FJPM, Kallewaard JW, Nijhuis H, Liem L, Vesper J, Fahey ME, Blomme B, Morgalla MH, Deer TR, Capobianco RA. Effectiveness and Safety of Dorsal Root Ganglion Stimulation for the Treatment of Chronic Pain: A Pooled Analysis. Neuromodulation. 2020 Feb;23(2):213-221. [PMC free article: PMC7079258] [PubMed: 31730273]

56.

Chauhan G, Srinivasan SK, Khanduja S. Dorsal Root Ganglion Stimulation Therapy for Refractory Idiopathic Pudendal Neuralgia. Cureus. 2023 Feb;15(2):e34681. [PMC free article: PMC9994636] [PubMed: 36909041]

57.

Burns SL, Majdak P, Adler AR, Jo C, Chiang MC, Yong RJ, Barreveld AM. Dorsal root ganglion stimulation for patients with chronic pelvic pain: A retrospective review of patient experiences and long-term outcomes. Interv Pain Med. 2024 Mar;3(1):100397. [PMC free article: PMC11372976] [PubMed: 39239506]

58.

Deer T, Pope J, Hunter C, Falowski S, Kapural L, Kramer J, Levy R. Safety Analysis of Dorsal Root Ganglion Stimulation in the Treatment of Chronic Pain. Neuromodulation. 2020 Feb;23(2):239-244. [PMC free article: PMC7065079] [PubMed: 30861617]

59.

Venturi M, Boccasanta P, Lombardi B, Brambilla M, Contessini Avesani E, Vergani C. Pudendal Neuralgia: A New Option for Treatment? Preliminary Results on Feasibility and Efficacy. Pain Med. 2015 Aug;16(8):1475-81. [PubMed: 25677417]

60.

Frank CE, Flaxman T, Goddard Y, Chen I, Zhu C, Singh SS. The Use of Pulsed Radiofrequency for the Treatment of Pudendal Neuralgia: A Case Series. J Obstet Gynaecol Can. 2019 Nov;41(11):1558-1563. [PubMed: 30910339]

61.

Zhu D, Fan Z, Cheng F, Li Y, Huo X, Cui J. The Efficacy of an Ultrasound-Guided Improved Puncture Path Technique of Nerve Block/Pulsed Radiofrequency for Pudendal Neuralgia: A Retrospective Study. Brain Sci. 2022 Apr 18;12(4) [PMC free article: PMC9031648] [PubMed: 35448041]

62.

Wang CL, Song T. The Clinical Efficacy of High-Voltage Long-Duration Pulsed Radiofrequency Treatment in Pudendal Neuralgia: A Retrospective Study. Neuromodulation. 2022 Dec;25(8):1372-1377. [PubMed: 33945192]

63.

Ji F, Zhou S, Li C, Zhang Y, Xu H. Therapeutic Efficacy of Ultrasound-Guided High-Voltage Long-Duration Pulsed Radiofrequency for Pudendal Neuralgia. Neural Plast. 2021;2021:9961145. [PMC free article: PMC8349273] [PubMed: 34373690]

64.

Valovska A, Peccora CD, Philip CN, Kaye AD, Urman RD. Sacral neuromodulation as a treatment for pudendal neuralgia. Pain Physician. 2014 Sep-Oct;17(5):E645-50. [PubMed: 25247915]

65.

Buffenoir K, Rioult B, Hamel O, Labat JJ, Riant T, Robert R. Spinal cord stimulation of the conus medullaris for refractory pudendal neuralgia: a prospective study of 27 consecutive cases. Neurourol Urodyn. 2015 Feb;34(2):177-82. [PubMed: 24249588]

66.

Gish B, Langford B, Sobey C, Singh C, Abdullah N, Walker J, Gray H, Hagedorn J, Ghosh P, Patel K, Deer T. Neuromodulation for the management of chronic pelvic pain syndromes: A systematic review. Pain Pract. 2024 Feb;24(2):321-340. [PubMed: 37726930]

67.

Vancaillie T, Kite L, Howard E, Chow J. Sacral neuromodulation for pelvic pain and pelvic organ dysfunction: A case series. Aust N Z J Obstet Gynaecol. 2018 Feb;58(1):102-107. [PubMed: 29218704]

68.

Meier KM, Vecellio PM, Killinger KA, Boura JA, Peters KM. Pudendal Neuromodulation is Feasible and Effective After Pudendal Nerve Entrapment Surgery. J Sex Med. 2022 Jun;19(6):995-1001. [PubMed: 35459633]

69.

Erdogru T, Avci E, Akand M. Laparoscopic pudendal nerve decompression and transposition combined with omental flap protection of the nerve (Istanbul technique): technical description and feasibility analysis. Surg Endosc. 2014 Mar;28(3):925-32. [PubMed: 24149853]

70.

Beco J, Climov D, Bex M. Pudendal nerve decompression in perineology: a case series. BMC Surg. 2004 Oct 30;4:15. [PMC free article: PMC529451] [PubMed: 15516268]

71.

Waxweiler C, Dobos S, Thill V, Bruyninx L. Selection criteria for surgical treatment of pudendal neuralgia. Neurourol Urodyn. 2017 Mar;36(3):663-666. [PubMed: 26999519]

72.

Bollens R, Mjaess G, Sarkis J, Chemaly AK, Nemr E, Daher K, Semaan A, Chebel JA, Absil F, Aoun F. Laparoscopic transperitoneal pudendal nerve and artery release for pudendal entrapment syndrome. Surg Endosc. 2021 Nov;35(11):6031-6038. [PubMed: 33048235]

73.

Moncada E, de San Ildefonso A, Flores E, Garrido L, Cano-Valderrama O, Vigorita V, Sánchez-Santos R. Right laparoscopic pudendal release + neurostimulator prosthesis (LION procedure) in pudendal neuralgia. Colorectal Dis. 2022 Oct;24(10):1243-1244. [PubMed: 35575432]

74.

Fernandes C, Viegas V, Artiles Medina A, Martins Silva C, San José L, López-Fando Lavalle L. Male pudendal nerve release assisted by laparoscopy and intraoperative neurophysiologic monitoring. Neurocirugia (Engl Ed). 2026 Mar-Apr;37(2):500714. [PubMed: 40738306]

75.

Leone JE, Middleton S. Nontraumatic Testicular Pain due to Sacroiliac-Joint Dysfunction: A Case Report. J Athl Train. 2016 Aug;51(8):651-657. [PMC free article: PMC5094844] [PubMed: 27626835]

76.

Sheng J, Liu S, Wang Y, Cui R, Zhang X. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast. 2017;2017:9724371. [PMC free article: PMC5494581] [PubMed: 28706741]

77.

Rayner L, Hotopf M, Petkova H, Matcham F, Simpson A, McCracken LM. Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs. Pain. 2016 Jul;157(7):1472-9. [PMC free article: PMC4912238] [PubMed: 26963849]

78.

Stockbridge EL, Suzuki S, Pagán JA. Chronic pain and health care spending: an analysis of longitudinal data from the Medical Expenditure Panel Survey. Health Serv Res. 2015 Jun;50(3):847-70. [PMC free article: PMC4450933] [PubMed: 25424348]

Disclosure: Jasmeen Kaur declares no relevant financial relationships with ineligible companies.

Disclosure: Stephen Leslie declares no relevant financial relationships with ineligible companies.

Disclosure: Paramvir Singh declares no relevant financial relationships with ineligible companies.